TrialEuropean journal of haematology2016

OCTET-CY: a phase II study to investigate the efficacy of post-transplant cyclophosphamide as sole graft-versus-host prophylaxis after allogeneic peripheral blood stem cell transplantation.

Udo Holtick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.